Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial.

@article{Stasi2006SequentialBA,
  title={Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial.},
  author={Savino M Di Stasi and Antonella Giannantoni and Arcangelo Giurioli and Marco Valenti and Germano Zampa and Luigi Storti and Francesco Attisani and Andrea De Carolis and Giovanni Capelli and Giuseppe Vespasiani and Robert L. Stephen},
  journal={The Lancet. Oncology},
  year={2006},
  volume={7 1},
  pages={43-51}
}
BACKGROUND The rationale for combining anticancer drugs has not been applied consistently to use of intravesical agents for treatment of superficial bladder cancer, for which immunotherapeutic BCG and chemotherapeutic mitomycin seem to be a potentially effective combination. We aimed to do a prospective, randomised comparison of BCG alone with that of sequential BCG and electromotive mitomycin in patients with stage pT1 bladder cancer. METHODS After transurethral resection and multiple… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 79 extracted citations

Similar Papers

Loading similar papers…